Title:
PREVENTION OF AND RECOVERY FROM DRUG-INDUCED OTOTOXICITY
Document Type and Number:
Japanese Patent JP2018076326
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide pharmaceutical compositions administered prior to onset of acoustic trauma, used for preventing hearing loss due to acoustic trauma.SOLUTION: A pharmaceutical composition has a multiparticulate JNK inhibitor or a multiparticulate neurotroph, allows sustained release of the JNK inhibitor or neurotroph into the ear, e.g. by intraperitoneal administration, for at least 5 days after the administration, and includes a gel formulation or a viscous formulation. The JNK inhibitor is SP600125 and neurotroph is IGF-1, preferably.SELECTED DRAWING: Figure 9
Inventors:
FABRICE PIU
YE QI-ANG
LUIS DELLAMARY
CARL LEBEL
YE QI-ANG
LUIS DELLAMARY
CARL LEBEL
Application Number:
JP2017228433A
Publication Date:
May 17, 2018
Filing Date:
November 28, 2017
Export Citation:
Assignee:
OTONOMY INC
International Classes:
A61K45/00; A61K9/06; A61K31/416; A61K31/4439; A61K31/4545; A61K31/506; A61K31/65; A61K38/18; A61K38/30; A61K47/34; A61P27/16; A61P43/00
Foreign References:
US20100016218A1 | 2010-01-21 | |||
WO2009132050A2 | 2009-10-29 |
Attorney, Agent or Firm:
Kazuhiro Kiyohara
Previous Patent: A method of manufacturing Viloxazine salt, and its new many forms
Next Patent: Controlled release peptide formulation
Next Patent: Controlled release peptide formulation